Macter is a prominent player in the Pakistani pharmaceutical industry, boasting a successful 30-year track record in producing pharma formulations. As one of the top 5 manufacturers by volume, the company's reputation for quality is noteworthy. With a strong corporate governance structure and recent investments from International FI’s, Macter stands well poised for growth and expansion. The company's commitment to customer satisfaction is evident as it prioritizes quality, teamwork, and innovation to meet evolving market needs. Its business areas revolve around contract manufacturing and branded generic formulations, with a focus on serving multinational companies. The manufacturing operations adhere to international cGMP standards and are ISO 9001:2008 certified, ensuring product excellence. Macter's dedication extends beyond business, encompassing a focus on employee development, fair compensation, and a sustainable, safe work environment, along with support for community causes. The company’s recent Private Equity Round investment at 01 June 2011 from JS Private Equity highlights investor confidence in Macter’s potential and long-term prospects. With its extensive manufacturing capabilities and a commitment to quality, Macter is positioned as an influential player in the pharmaceutical industry.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Private Equity Round | Unknown | 1 | JS Private Equity | 01 Jun 2011 |
No recent news or press coverage available for Macter International Limited.